Home › Funds › TANAKA CAPITAL MANAGEMENT INC › NUVB
TANAKA CAPITAL MANAGEMENT INC position in NUVB
NUVATION BIO INC · Health Care
TANAKA CAPITAL MANAGEMENT INC reported holding 901,825 shares of NUVB (NUVATION BIO INC) in its Q1 2026 13F filing — a position valued at US$3.9M, representing 6.46% of its reported portfolio and ranking #6 among its reported holdings. TANAKA CAPITAL MANAGEMENT INC has disclosed NUVB holdings in 3 of the last 3 reported quarters, going back to Q3 2025.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How TANAKA CAPITAL MANAGEMENT INC's NUVB position evolved
TANAKA CAPITAL MANAGEMENT INC first disclosed a stake in NUVB in Q3 2025 at 685,105 shares (US$2.5M). The position peaked in Q4 2025 at 841,605 shares, worth US$7.5M. Across 3 filings, TANAKA CAPITAL MANAGEMENT INC increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q1 2026) shows 901,825 shares valued at US$3.9M — an increase of 60,220 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 685.11K | $2.54M | New |
| Q4 2025 | 841.61K | $7.54M | Add |
| Q1 2026 | 901.83K | $3.87M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About NUVB and 13F data
NUVB (NUVATION BIO INC) is a Health Care company. 53 other funds we track also report a position in NUVB — the largest reported positions include Decheng Capital LLC (US$147.4M), Omega Fund Management, LLC (US$45.9M), Laurion Capital Management LP (US$44.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding NUVB
- Decheng Capital LLC 25.95M sh · $147.42M · Q2 2026
- Omega Fund Management, LLC 8.08M sh · $45.90M · Q2 2026
- Laurion Capital Management LP 7.82M sh · $44.42M · Q2 2026
- Context Capital Management, LLC 30.00M sh · $31.29M · Q2 2026
- Polar Asset Management Partners Inc. 25.00M sh · $26.10M · Q2 2026
- Duquesne Family Office LLC 4.54M sh · $25.79M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 3.30M sh · $18.74M · Q2 2026
- Redmile Group, LLC 3.03M sh · $17.22M · Q2 2026
- Knoll Capital Management, LLC 1.60M sh · $9.08M · Q2 2026
- ESSEX INVESTMENT MANAGEMENT CO LLC 1.34M sh · $7.53M · Q3 2026
- ABRAMS CAPITAL MANAGEMENT, L.P. 1.27M sh · $7.22M · Q2 2026
More on TANAKA CAPITAL MANAGEMENT INC
FAQ
How long has TANAKA CAPITAL MANAGEMENT INC held NUVB?
TANAKA CAPITAL MANAGEMENT INC has disclosed NUVB holdings in 3 of the last 3 reported quarters, going back to Q3 2025.
What is TANAKA CAPITAL MANAGEMENT INC's current position in NUVB?
As of Q1 2026, TANAKA CAPITAL MANAGEMENT INC holds 901.83K shares of NUVB (NUVATION BIO INC), valued at $3.87M, representing 6.46% of its reported portfolio and ranking #6.
Has TANAKA CAPITAL MANAGEMENT INC been buying or selling NUVB?
In the latest 13F filing (Q1 2026), TANAKA CAPITAL MANAGEMENT INC increased its position in NUVB. The position peaked in Q4 2025 at 841.61K shares.
Which other funds hold NUVB?
Other major institutional holders of NUVB include Decheng Capital LLC, Omega Fund Management, LLC, Laurion Capital Management LP, among 53 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.